BIOXCEL THERAPEUTICS INC

CUSIP: 09075P105 Class: Common Stock

Pennant Investors, LP's Holding History (CIK: 0001759176)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 83,900 Value ($000) $107 Avg Close — Range —
Q1 2024
Shares 83,900 Value ($000) $237 Avg Close — Range —
Q4 2023
Shares 83,900 Value ($000) $248 Avg Close — Range —